The pen needles industry is poised for substantial growth in the near future as advancements in diabetes management and injectable therapies continue to drive innovation. With a rising global prevalence of diabetes and an increasing emphasis on patient convenience and safety, pen needles are expected to evolve with more user-friendly designs, enhanced precision, and compatibility with a wider range of drug formulations.
Pen Needles Market in terms of revenue was estimated to be worth $1.6 Billion in 2023 and is poised to reach $2.5 Billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028 according to a new report by MarketsandMarkets™.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613
Browse in-depth TOC on “Pen Needles Market”
150 – Tables
80 – Figures
250 – Pages
“Discounts offered on the online purchases of pen needles to drive the growth of this segment”
Online purchase is the fastest growing segment of the pen needles market, by mode of purchase. The convenience of online purchases, and time-efficient drive the growth of this segment. Additionally, patients who need pen needles on a regular basis can even get subscriptions for a monthly supply, which further makes it more convenient.
The over-the counter purchase segment accounted for the largest share of the pen needles market by mode of purchase, in 2022. This is due to the large number of patients buying pen needles from local pharmacies without the need of a prescription. Additionally, distributors and suppliers provide discounts to hospitals and clinics on bulk purchases, which further contributes to the large share of this segment.
“Asia Pacific likely to emerge as the fastest-growing pen needles market, globally”
The pen needles market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. Asia Pacific attributes to the highest growth rate amongst the other regions. The emerging Asian countries, such as China, India, and Japan, are offering significant growth opportunities for market players. The expansion of healthcare infrastructure and increase in disposable incomes, increase incidences of diabetes are factors which are likely to support the growth of pen needles market in the region.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613
Pen Needles Market Dynamics:
Drivers:
- Growing adoption of self-administration
Restraints:
- Preference for alternative modes of drug delivery
Opportunities:
- Emerging markets
Challenge:
- Reuse of pen needles
Key Market Players of Pen Needles Industry:
The key players in the pen needles market B. Braun Melsungen AG (Germany), Embecta Corp. (US), and Novo Nordik A/S (Germany). These companies adopted strategies such as collaborations, partnerships, and investments to strengthen their presence in the market.
Recent Developments:
- In February 2023, Montmed, Inc. (Canada) announced issuance of a second US Patent for Sitesmart Pen Needles.
- In April 2022, Embecta Corp. (US) completed the spin-off from Becton, Dickinson and Company (US) and started operating globally as a standalone pure-play diabetes care company.
- In February 2021, UltiMed, Inc. (US) launched UltiCare safety pen needles in two sizes, 5mm 30G and 8mm 30 G.
- In January 2021, NHS (UK) chose Owen Mumford (UK) as the sole supplier of safety pen needles. With this partnership, Owen’s pen needles will be used in all NHS Wales hospitals.
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=75948613
